5 av 37 (14%) PUP och 4 av 23 (17%) MTP patienter behandlade med KOGENATE Bayer utvecklade inhibitorer: ###>Five out of 37 (14%) PUP and 4 out of 23 (17%) MTP patients treated with KOGENATE Bayer developed inhibitors: